Literature DB >> 15316828

Effect of folate-binding protein on intestinal transport of folic acid and 5-methyltetrahydrofolate across Caco-2 cells.

Miriam Verwei1, Henk van den Berg, Robert Havenaar, John P Groten.   

Abstract

BACKGROUND: Milk products are a potential matrix for fortification with synthetic folic acid or natural 5-methyltetrahydrofolate (5-CH3-H4folate) to enhance the daily folate intake. In milk, folate occurs bound to folate-binding proteins (FBP). Our previous studies with an in vitro gastrointestinal model showed that 70% of the initial FBP content of the milk product was retained in the duodenal lumen. While folic acid remained bound to FBP after gastric passage, 5-CH3-H4folate was mainly present as free folate in the duodenal lumen. AIM OF THE STUDY: To investigate the effect of FBP on the absorption of folic acid and 5-CH3-H4folate from the intestinal lumen.
METHODS: The transport of [3H]-folic acid and [14C]-5-CH3-H4folate across enterocytes was studied in the presence or absence of bovine FBP using monolayers of Caco-2 cells grown on semi-permeable inserts in a two-compartment model. The apparent permeability coefficients (P(app)) of folic acid and 5-CH3-H4folate were determined and compared with the permeability of reference compounds for low (mannitol) and high (caffeine) permeability.
RESULTS: The transport from the apical to the basolateral side of the Caco-2 cells was higher (P < 0.05) for folic acid (P(app) = 1.7*10(-6) cm/s) than for 5-CH3-H4folate (P(app) = 1.4*10(-6) cm/s) after 2 h incubation to 1 microM folic acid or 5-CH3-H4folate test solutions (pH 7). The permeability of folic acid and 5-CH3-H4folate across Caco-2 monolayers appeared to be higher (P < 0.05) than that of mannitol (P(app) = 0.5*10(-6) cm/s) but lower (P < 0.05) than that of caffeine (P(app) = 34*10(-6) cm/s). The addition of FBP to the medium led to a lower (P < 0.05) intestinal transport and cellular accumulation of folic acid and 5-CH3-H4folate.
CONCLUSIONS: Compared to the reference compounds, folic acid and 5-CH3-H4folate showed a moderate permeability across Caco-2 cells, which indicates that folate absorption from the intestinal lumen is not likely to be complete. The intestinal transport of folic acid and 5-CH3-H4folate was found to be dependent on the extent of binding to FBP at the luminal side of the cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15316828     DOI: 10.1007/s00394-004-0516-9

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  34 in total

Review 1.  Folate-binding proteins.

Authors:  C Wagner
Journal:  Nutr Rev       Date:  1985-10       Impact factor: 7.110

2.  In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth.

Authors:  S Yee
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

3.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

Authors:  P Artursson; J Karlsson
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

4.  Detection of a milk factor that facilitates folate uptake by intestinal cells.

Authors:  N Colman; N Hettiarachchy; V Herbert
Journal:  Science       Date:  1981-03-27       Impact factor: 47.728

5.  A pH-dependent, carrier-mediated system for transport of 5-methyltetrahydrofolate in rat jejunum.

Authors:  H M Said; W B Strum
Journal:  J Pharmacol Exp Ther       Date:  1983-07       Impact factor: 4.030

6.  Intestinal transport of 5-methyltetrahydrofolate.

Authors:  J Selhub; G M Powell; I H Rosenberg
Journal:  Am J Physiol       Date:  1984-05

7.  Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line.

Authors:  M C Grès; B Julian; M Bourrié; V Meunier; C Roques; M Berger; X Boulenc; Y Berger; G Fabre
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

8.  The binding of folic acid and 5-methyltetrahydrofolate to folate-binding proteins during gastric passage differs in a dynamic in vitro gastrointestinal model.

Authors:  Miriam Verwei; Karin Arkbåge; Hans Mocking; Robert Havenaar; John Groten
Journal:  J Nutr       Date:  2004-01       Impact factor: 4.798

9.  The preparation and properties of folate-binding protein from cow's milk.

Authors:  D N Salter; K J Scott; H Slade; P Andrews
Journal:  Biochem J       Date:  1981-02-01       Impact factor: 3.857

10.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

View more
  5 in total

1.  Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic.

Authors:  Thommey P Thomas; Melvin Joice; Madhuresh Sumit; Justin E Silpe; Alina Kotlyar; Sophia Bharathi; Jolanta Kukowska-Latallo; James R Baker; Seok Ki Choi
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

2.  Plasma folate concentrations after a single dose ingestion of whole and skimmed folic acid fortified milks in healthy subjects.

Authors:  María Achón; Angeles Arrate; Elena Alonso-Aperte; Gregorio Varela-Moreiras
Journal:  Eur J Nutr       Date:  2010-06-26       Impact factor: 5.614

3.  Folates in bread: retention during bread-making and in vitro bioaccessibility.

Authors:  Veronica Öhrvik; Helena Öhrvik; Jonas Tallkvist; Cornelia Witthöft
Journal:  Eur J Nutr       Date:  2010-02-04       Impact factor: 5.614

4.  Folic acid transport via high affinity carrier-mediated system in human retinoblastoma cells.

Authors:  Viral Kansara; Durga Paturi; Shuanghui Luo; Ripal Gaudana; Ashim K Mitra
Journal:  Int J Pharm       Date:  2007-12-23       Impact factor: 5.875

Review 5.  Mechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic delivery.

Authors:  Pamela T Wong; Seok Ki Choi
Journal:  Int J Mol Sci       Date:  2015-01-13       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.